Evidenze Health España SL

Evidenze Health España SL is a Spanish contract research organization (CRO) headquartered in Barcelona. The company operates under the Evidenze brand and presents itself as a 'full value' CRO with global reach, distinguishing its model from traditional 'full-service' CROs. Rather than limiting itself to execution, Evidenze describes its approach as combining deep therapeutic expertise, technology, and strategic insight to accelerate trials, unlock the potential of data, optimize costs, and provide tailored strategic and regulatory consultancy. The firm's core services span the clinical development lifecycle, with a stated emphasis on study start-up and clinical operations. Its study start-up offering covers regulatory coordination for clinical study approvals, preparation of essential documents such as protocols and patient information sheets/informed consent (PIS/IC), study files (TMF/ISF), applications to national and regional health authorities and ethics committees, and related negotiation and signature processes. Evidenze markets itself as a partner 'from beginning to end' for sponsors. Evidenze targets biotechs and small and medium-sized pharmaceutical companies with tailor-made solutions, and it highlights wide experience across multiple therapeutic areas, including oncology. Its positioning centers on generating scientific evidence and transforming it into knowledge to improve clinical practice and add value to the health sector. The company is associated with Barcelona, Spain, and its website is evidenze.com. Public evidence available for this dossier is limited to its official website and a Wikidata entry identifying it as a company in Barcelona; details such as founding year, founders, ownership structure, and executive leadership are not established by the supplied sources and are therefore omitted.

Evidenze Health España SL is a company based in Barcelona, Spain, operating as a contract research organization under the Evidenze brand. The available evidence does not establish a founding date or a detailed corporate chronology. What is documented is the company's current market positioning and service model. Evidenze presents itself as a 'full value' CRO with global reach. In its own framing, it is 'more than a full service CRO,' and its 'Full Value' approach is said to combine deep expertise, cutting-edge technology, and strategic insights. The company states that this approach is intended to accelerate trials, unlock the full potential of data, optimize costs, and provide tailored strategic consultancy and regulatory approaches. Its stated purpose is to generate scientific evidence and transform it into knowledge to improve clinical practice and add value to the health sector. Operationally, Evidenze describes a partner model that runs 'from beginning to end,' with core services including Study Start-up and Clinical Operations. Its study start-up work involves comprehensive coordination of regulatory processes for clinical study approvals, including preparation and obtaining of essential documents such as the protocol and the Patient Information Sheet/Informed Consent (PIS/IC), preparation of study files (TMF/ISF), applications for authorization to national and regional health authorities and ethics committees, and negotiation and signature processes. The company markets these capabilities to biotechs and small and medium-sized pharma with tailor-made solutions, and it highlights wide experience across therapeutic areas, including oncology. Because the supplied sources are limited to the company's official website and a Wikidata entry identifying it as a company in Barcelona, this history reflects the brand's self-described model and market focus rather than a verified timeline of corporate events. No founding year, founder names, ownership details, funding events, acquisitions, or leadership changes are established by the evidence and are therefore not asserted here.

A 'full value' CRO with global reach, going beyond traditional full-service execution by combining expertise, technology, and strategic insight for biotechs and small-to-medium pharma.

• Study Start-up

  Comprehensive coordination of regulatory processes for clinical study approvals, including preparation of essential documents (protocol, PIS/IC, TMF/ISF), applications to national and regional health authorities and ethics committees, and negotiation and signature processes.

• Clinical Operations

  Clinical operations services offered as part of Evidenze's end-to-end CRO partner model.

1. 1Evidenze CRO | The full value CRO with Global reach.evidenze.com
2. 2Evidenze Health España SL (Spain) - Wikidatawikidata.org